| pubmed-article:19505904 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19505904 | lifeskim:mentions | umls-concept:C1706077 | lld:lifeskim |
| pubmed-article:19505904 | lifeskim:mentions | umls-concept:C0596244 | lld:lifeskim |
| pubmed-article:19505904 | lifeskim:mentions | umls-concept:C0080356 | lld:lifeskim |
| pubmed-article:19505904 | lifeskim:mentions | umls-concept:C0007328 | lld:lifeskim |
| pubmed-article:19505904 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:19505904 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:19505904 | pubmed:dateCreated | 2009-6-9 | lld:pubmed |
| pubmed-article:19505904 | pubmed:abstractText | Inhibitors of histone deacetylases (HDAC) have shown promise as targeted cancer therapy. Valproate, an older anticonvulsant, has been shown to possess HDAC inhibitory activity. We undertook this case-control study to clarify whether long-term users of valproate had a reduced cancer incidence. If so, it would support HDAC inhibition as a pharmacologic principle in chemoprevention. | lld:pubmed |
| pubmed-article:19505904 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19505904 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19505904 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19505904 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19505904 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19505904 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19505904 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19505904 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19505904 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19505904 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:19505904 | pubmed:issn | 1538-7755 | lld:pubmed |
| pubmed-article:19505904 | pubmed:author | pubmed-author:FriisSørenS | lld:pubmed |
| pubmed-article:19505904 | pubmed:author | pubmed-author:BjerrumLarsL | lld:pubmed |
| pubmed-article:19505904 | pubmed:author | pubmed-author:AndersenMorte... | lld:pubmed |
| pubmed-article:19505904 | pubmed:author | pubmed-author:GrønbaekKirst... | lld:pubmed |
| pubmed-article:19505904 | pubmed:author | pubmed-author:HallasJesperJ | lld:pubmed |
| pubmed-article:19505904 | pubmed:author | pubmed-author:StøvringHenri... | lld:pubmed |
| pubmed-article:19505904 | pubmed:author | pubmed-author:NarverudSverr... | lld:pubmed |
| pubmed-article:19505904 | pubmed:author | pubmed-author:HeyerdahlThom... | lld:pubmed |
| pubmed-article:19505904 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19505904 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:19505904 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19505904 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19505904 | pubmed:pagination | 1714-9 | lld:pubmed |
| pubmed-article:19505904 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:19505904 | pubmed:meshHeading | pubmed-meshheading:19505904... | lld:pubmed |
| pubmed-article:19505904 | pubmed:meshHeading | pubmed-meshheading:19505904... | lld:pubmed |
| pubmed-article:19505904 | pubmed:meshHeading | pubmed-meshheading:19505904... | lld:pubmed |
| pubmed-article:19505904 | pubmed:meshHeading | pubmed-meshheading:19505904... | lld:pubmed |
| pubmed-article:19505904 | pubmed:meshHeading | pubmed-meshheading:19505904... | lld:pubmed |
| pubmed-article:19505904 | pubmed:meshHeading | pubmed-meshheading:19505904... | lld:pubmed |
| pubmed-article:19505904 | pubmed:meshHeading | pubmed-meshheading:19505904... | lld:pubmed |
| pubmed-article:19505904 | pubmed:meshHeading | pubmed-meshheading:19505904... | lld:pubmed |
| pubmed-article:19505904 | pubmed:meshHeading | pubmed-meshheading:19505904... | lld:pubmed |
| pubmed-article:19505904 | pubmed:meshHeading | pubmed-meshheading:19505904... | lld:pubmed |
| pubmed-article:19505904 | pubmed:meshHeading | pubmed-meshheading:19505904... | lld:pubmed |
| pubmed-article:19505904 | pubmed:meshHeading | pubmed-meshheading:19505904... | lld:pubmed |
| pubmed-article:19505904 | pubmed:meshHeading | pubmed-meshheading:19505904... | lld:pubmed |
| pubmed-article:19505904 | pubmed:meshHeading | pubmed-meshheading:19505904... | lld:pubmed |
| pubmed-article:19505904 | pubmed:meshHeading | pubmed-meshheading:19505904... | lld:pubmed |
| pubmed-article:19505904 | pubmed:meshHeading | pubmed-meshheading:19505904... | lld:pubmed |
| pubmed-article:19505904 | pubmed:meshHeading | pubmed-meshheading:19505904... | lld:pubmed |
| pubmed-article:19505904 | pubmed:meshHeading | pubmed-meshheading:19505904... | lld:pubmed |
| pubmed-article:19505904 | pubmed:meshHeading | pubmed-meshheading:19505904... | lld:pubmed |
| pubmed-article:19505904 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19505904 | pubmed:articleTitle | Cancer risk in long-term users of valproate: a population-based case-control study. | lld:pubmed |
| pubmed-article:19505904 | pubmed:affiliation | Research Unit of Clinical Pharmacology, University of Southern Denmark, Odense C, Denmark. jhallas@health.sdu.dk | lld:pubmed |
| pubmed-article:19505904 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19505904 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
